Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kezar Life Sciences Inc
(NQ:
KZR
)
0.5730
+0.0130 (+2.32%)
Streaming Delayed Price
Updated: 9:41 AM EDT, Sep 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Kezar Life Sciences Inc
< Previous
1
2
3
Next >
Kezar Life Sciences to Present at the Jefferies London Healthcare Conference
November 11, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Oxford Finance Provides $50 Million Credit Facility to Kezar Life Sciences, Inc.
November 10, 2021
From
Oxford Finance LLC
Via
Business Wire
Kezar Reports Third Quarter Financial Results and Provides Business Update
November 09, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar to Host Virtual Investor and Analyst Day on November 15, 2021
November 03, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces First Patient Dosed in Phase 1 Trial of KZR-261 in Advanced Solid Tumor Malignancies
October 27, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Appoints Gitanjali Jain as Vice President, Investor Relations and External Affairs
October 05, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in Two Upcoming Investor Conferences
September 02, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Announces Completion of Enrollment of Its Phase 2 PRESIDIO Clinical Trial of KZR-616 in Polymyositis and Dermatomyositis
August 23, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates
August 12, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021
July 08, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Announces Formation of Clinical Advisory Committee
June 08, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021
June 02, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Appoints Rheumatology Industry Expert, Micki Klearman, MD, to its Board of Directors
June 01, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference
May 27, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Host Virtual MISSION Phase 1b Data Update Call at EULAR 2021 on June 2, 2021
May 26, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates
May 12, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Recognized as 2021 Bay Area Best Places to Work
May 10, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting
April 10, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.